United Capital Financial Advisers LLC Has $19.64 Million Stock Position in Clorox Co (NYSE:CLX)

Share on StockTwits

United Capital Financial Advisers LLC grew its position in Clorox Co (NYSE:CLX) by 7.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 128,252 shares of the company’s stock after purchasing an additional 8,549 shares during the period. United Capital Financial Advisers LLC’s holdings in Clorox were worth $19,637,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Profund Advisors LLC lifted its position in shares of Clorox by 4.7% in the second quarter. Profund Advisors LLC now owns 2,518 shares of the company’s stock worth $386,000 after purchasing an additional 113 shares in the last quarter. Bank of Nova Scotia raised its position in Clorox by 2.6% during the second quarter. Bank of Nova Scotia now owns 25,382 shares of the company’s stock valued at $3,886,000 after acquiring an additional 647 shares in the last quarter. Scotia Capital Inc. raised its position in Clorox by 104.9% during the second quarter. Scotia Capital Inc. now owns 7,496 shares of the company’s stock valued at $1,148,000 after acquiring an additional 3,837 shares in the last quarter. Banco de Sabadell S.A raised its position in Clorox by 18.8% during the second quarter. Banco de Sabadell S.A now owns 12,683 shares of the company’s stock valued at $1,942,000 after acquiring an additional 2,005 shares in the last quarter. Finally, Bernardo Wealth Planning LLC raised its position in Clorox by 13.2% during the second quarter. Bernardo Wealth Planning LLC now owns 1,541 shares of the company’s stock valued at $236,000 after acquiring an additional 180 shares in the last quarter. Institutional investors own 78.20% of the company’s stock.

In other Clorox news, Director A D. David Mackay sold 3,400 shares of Clorox stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Diego J. Barral sold 1,987 shares of Clorox stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,609 shares of company stock worth $2,497,443. 1.40% of the stock is currently owned by corporate insiders.

Shares of Clorox stock traded down $1.75 during midday trading on Friday, hitting $158.45. The company had a trading volume of 37,664 shares, compared to its average volume of 895,737. The business’s 50 day simple moving average is $159.87 and its two-hundred day simple moving average is $156.21. The stock has a market cap of $19.90 billion, a PE ratio of 25.06, a P/E/G ratio of 4.99 and a beta of 0.38. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55. Clorox Co has a 1-year low of $141.53 and a 1-year high of $167.70.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. Clorox’s quarterly revenue was down 3.8% on a year-over-year basis. During the same quarter last year, the company posted $1.66 earnings per share. On average, sell-side analysts expect that Clorox Co will post 6.4 EPS for the current fiscal year.

CLX has been the topic of several analyst reports. Morgan Stanley increased their price target on Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Citigroup set a $156.00 price target on Clorox and gave the company a “hold” rating in a report on Thursday, May 23rd. UBS Group increased their price target on Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a report on Friday, August 2nd. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target on the stock in a report on Monday, July 29th. Finally, ValuEngine downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $154.07.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Stop Order

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.